1,422 Shares in Intuitive Surgical, Inc. $ISRG Bought by Paladin Partners LLC

Paladin Partners LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, Holdings Channel reports. The fund bought 1,422 shares of the medical equipment provider’s stock, valued at approximately $566,000. Intuitive Surgical accounts for 0.4% of Paladin Partners LLC’s holdings, making the stock its 28th largest position.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Trust Co. of Vermont acquired a new stake in Intuitive Surgical during the second quarter worth about $1,680,000. Hikari Power Ltd purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $5,619,000. Plato Investment Management Ltd purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $4,315,000. J.Safra Asset Management Corp acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $58,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at approximately $1,335,753,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 72 shares of Intuitive Surgical stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the sale, the director directly owned 179 shares in the company, valued at approximately $70,364.90. The trade was a 28.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the sale, the director owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. This trade represents a 0.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 17,088 shares of company stock valued at $6,941,913. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 1.1%

ISRG opened at $390.33 on Tuesday. The firm’s fifty day simple moving average is $390.88 and its two-hundred day simple moving average is $439.71. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The company has a market cap of $137.90 billion, a price-to-earnings ratio of 44.71, a PEG ratio of 2.85 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the previous year, the company earned $1.81 earnings per share. The company’s quarterly revenue was up 18.4% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ISRG. Jefferies Financial Group decreased their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research note on Wednesday, April 22nd. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft dropped their target price on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Leerink Partners reduced their price target on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a report on Friday, July 17th. Finally, Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Twenty-two investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $508.68.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.